TG Therapeutics, Inc. has announced a conference call scheduled for May 5, 2025, at 8:30 AM ET to discuss its first quarter financial results and provide a business outlook for the remainder of 2025.

ABOUT TG THERAPEUTICS TG Therapeutics is a fully integrated, commercial stage, biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell ...

NEW YORK, Oct. 31, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (TGTX), today announced that a conference call will be held, Monday, November 3, 2025, at 8:30 AM ET to discuss results for the third ...

Gender Odyssey, Seattle’s annual transgender conference, is in full swing with thousands of therapists, families, and advocates coming together in what is predicted to be the largest of the yearly ...

Republican leaders from Congress expressed "serious concern" with the Mountain West Conference about transgender women participating in women's sports. Thirteen officials signed a letter to Mountain ...

NEW YORK, April 30, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (TGTX), today announced that a conference call will be held tomorrow, Wednesday, May 1, 2024, at 8:30 AM ET to discuss results for ...

NEW YORK, July 30, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that a conference call will be held, Monday, August 4, 2025, at 8:30 AM ET to discuss results for the ...